Upgrade to SI Premium - Free Trial

Spero Therapeutics (SPRO)

2.82 -0.16 (5.37%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/12/26)

Latest Headlines

Compass Pathways elects Kathleen Tregoning to board of directors May 28, 2026 6:30 AM - StreetInsider Compass Pathways Elects Kathleen Tregoning to Board of Directors May 28, 2026 6:30 AM - BizWire SmartPros Ltd. (SPRO) Reports Q1 Loss of $0.13 May 13, 2026 4:09 PM - StreetInsider Form 10-Q Spero Therapeutics, Inc. For: Mar 31 May 13, 2026 4:06 PM - SEC Filing Spero Therapeutics Announces First Quarter 2026 Operating Results and Provides Business Update May 13, 2026 4:05 PM - Globe NewsWire Form 8-K Spero Therapeutics, Inc. For: May 13 May 13, 2026 4:02 PM - SEC Filing Form 4 Spero Therapeutics, Inc. For: May 04 Filed by: Rajavelu Esther May 6, 2026 9:54 PM - SEC Filing Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026 May 5, 2026 4:05 PM - Globe NewsWire Form ARS Spero Therapeutics, Inc. For: Dec 31 April 27, 2026 4:43 PM - SEC Filing Form DEFA14A Spero Therapeutics, Inc. April 27, 2026 4:39 PM - SEC Filing Form DEF 14A Spero Therapeutics, Inc. For: Jun 23 April 27, 2026 4:31 PM - SEC Filing Form PRE 14A Spero Therapeutics, Inc. For: Jun 23 April 13, 2026 5:27 PM - SEC Filing Spero Therapeutics (SPRO) Tops Q4 EPS by 73c, Beats on Revenue March 26, 2026 4:13 PM - StreetInsider Form 8-K Spero Therapeutics, Inc. For: Mar 26 March 26, 2026 4:12 PM - SEC Filing Form 10-K Spero Therapeutics, Inc. For: Dec 31 March 26, 2026 4:06 PM - SEC Filing Spero Therapeutics Announces Fourth Quarter and Full Year 2025 Operating Results and Provides a Business Update March 26, 2026 4:05 PM - Globe NewsWire Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026 March 18, 2026 4:05 PM - Globe NewsWire Full Article List